drugset / Trial / NCT03069339
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
RandomizedParallel-groupOpen-labelTreatment
Summary
Study Design: Open labeled randomized controlled trial. The study will be conducted on patients attending outpatient or admitted to admitted to Department of Hepatology from January 2017 to December 2018 at ILBS, New Delhi
Timeline
- Start
- 2017-03-15
- Primary completion
- 2020-11-30
- Completion
- 2020-11-30
Outcome
Met primary endpoint
paper significantly reduced the incidence of first variceal bleed by 62.9% as compared with group B (HR 0.37, 95% CI 0.192 to 0.716, p<0.003) PMID 39067870 ↗
paper by 69.3% as compared with group A (HR 0.31, 95% CI 0.163 to 0.578, <0.001) PMID 39067870 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 12.5 mg | — |